The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Mon., Mar. 30, 10:02 PM

Slide #4. Synta Pharmaceuticals Corp. Secondary Offering

Company: Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
Date announced: 3/30/2015
Secondary Offering Details: Synta Pharmaceuticals Corp. (NASDAQ:SNTA) today announced that it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Synta intends to grant the underwriters a 30-day option to purchase additional shares of its common stock.

Synta Pharmaceuticals is engaged in discovering, developing, and commercializing small molecule drugs for patients with severe medical conditions, including cancer and chronic inflammatory diseases. Co.'s clinical-stage programs in oncology include: Ganetespib, which is being evaluated in cancer clinical trials including its GALAXY NSCLC program in combination with docetaxel chemotherapy, and as monotherapy in certain genetically-defined targeted patient populations; and Elesclomol, which is being evaluated in combination with paclitaxel in ovarian cancer. Co.'s preclinical-stage programs focusing on inflammatory diseases include CRACM Ion Channel Inhibitors and IL-12/23 Inhibitors.
Open the SNTA Page at The Online Investor »

Company Name:  Synta Pharmaceuticals Corp
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding SNTA:  15
Total Market Value Held by ETFs:  $7.91M
Total Market Capitalization:  $251.00M
% of Market Cap. Held by ETFs:  3.15%

Open the SNTA Page at The Online Investor (in a new window) »

March 30, 2015    10:02 PM Eastern
Quotes delayed 20 minutes

Buy (2.67 out of 4)
26th percentile
(ranked lower than approx. 74% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.